Skip to main content

USANA Health Sciences Inc.

corporate_fare Company Profile

USANA Health Sciences Inc.

USNA·NYSE·Life Sciences·CIK 0000896264

USANA Health Sciences, Inc. develops and manufactures high-quality nutritional supplements, functional foods, and personal care products sold globally. Founded in 1992 by Myron W. Wentz, Ph.D., the company focuses on science-based products for long-term health and wellness, emphasizing continuous product innovation and scientific research. In 2025, the company generated $925 million in net sales and had approximately 387,000 active Customers in its core nutritional business. The company operates in 25 geographic markets worldwide, distributing products primarily through a direct selling channel. Mainland China is USANA's largest market, accounting for approximately 41.3% of net sales and approximately 49.9% of core nutritional active Customers. As a U.S.-based multinational corporation, its operating results are influenced by currency fluctuations and economic and political conditions in its global markets. USANA is subject to various laws and regulations in the United States, China, and other operating markets concerning its products and distribution methods. In December 2024, USANA acquired a 78.85% ownership interest in Hiya Health Products, LLC, a direct-to-consumer provider of children's health and wellness products. The company also acquired Rise in 2022 and has since expanded Rise's product offering, distribution channel, and customer base. USANA is a U.S. public company listed on the New York Stock Exchange.

USANA Health Sciences Inc. (NYSE:USNA) is a publicly traded company in the Life Sciences sector. Wiseek monitors USNA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Q1 Earnings Decline 20% Amidst Core Customer Losses, Despite Growth in New Segments
  • USANA Health Sciences Q1 Revenue Flat, Profit Drops; Reaffirms FY26 Guidance
  • USANA Health Sciences Reports Mixed Q1 Results, Reaffirms 2026 Outlook Amidst Omnichannel Transformation
  • USANA Health Sciences Details CEO Return, Unmet Performance Targets, and Executive Compensation for 2026 Annual Meeting
  • USANA Reports 74% Drop in Net Earnings, 72% Effective Tax Rate, and Goodwill Impairment Amid Core Business Decline

Financial Snapshot

Fiscal year ended January 3, 2026
Revenue
$925.26M
Net Income
$10.76M
Diluted EPS
$0.58
Op. Cash Flow
$22.35M
Free Cash Flow
$8.53M
Gross Profit
$724.4M
Operating Income
$37.43M
Cash & Equivalents
$158.38M
Debt / Equity
0.00×
Net Margin
1.2%
Shares Outstanding
18.28M sh
Source: 10-K · filed 2026-03-16 · accession 0000896264-26-000021
Browse all tickers starting with U →
$19.91
52-week range · as of 2026-05-12 $16.6 – $38.32
Market cap
$367.6M
Volume
86.9K (0.7× avg)
3-mo avg 117.3K
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed USNA - Latest Insights

USNA
May 12, 2026, 4:35 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $17.36
Real-time Price: $19.91 info
Change: +$2.55 (+15%) info
Market Cap: $367.599M info
USNA
May 05, 2026, 4:33 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $19.26
Real-time Price: $19.91 info
Change: +$0.650 (+3%) info
Market Cap: $367.599M info
USNA
May 05, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.26
Real-time Price: $19.91 info
Change: +$0.650 (+3%) info
Market Cap: $367.599M info
USNA
Apr 07, 2026, 4:50 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $17.54
Real-time Price: $19.91 info
Change: +$2.37 (+14%) info
Market Cap: $367.599M info
USNA
Mar 16, 2026, 2:57 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $17.72
Real-time Price: $19.91 info
Change: +$2.19 (+12%) info
Market Cap: $367.599M info
USNA
Feb 17, 2026, 8:33 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $23.09
Real-time Price: $19.91 info
Change: -$3.18 (-14%) info
Market Cap: $367.599M info
USNA
Feb 11, 2026, 4:51 PM EST
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $21.14
Real-time Price: $19.91 info
Change: -$1.23 (-6%) info
Market Cap: $367.599M info
USNA
Jan 12, 2026, 6:29 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.14
Real-time Price: $19.91 info
Change: -$0.230 (-1%) info
Market Cap: $367.599M info
USNA
Jan 08, 2026, 9:01 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.57
Real-time Price: $19.91 info
Change: +$0.340 (+2%) info
Market Cap: $367.599M info